Wallerian degeneration in ICAM-1-deficient mice.

Por Vougioukas, V. I., Roeske, S., Michel, U., Brück, W.
Publicado em 1998

High expression levels of erythropoietin and its receptor are not correlated with shorter survival in human glioblastoma

Por BRUNOTTE, J., BOCK, H.C., BRÜCK, W., HEMMERLEIN, B., STRIK, H.
Publicado em 2011

BROADENED AND ELEVATED HUMORAL IMMUNE RESPONSE TO EBNA1 IN PEDIATRIC MULTIPLE SCLEROSIS

Por Lünemann, J D., Huppke, P, Roberts, S, Brück, W, Gärtner, J, Münz, C
Publicado em 2008

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis

Por Jarius, S., König, F.B., Metz, I., Ruprecht, K., Paul, F., Brück, W., Wildemann, B.
Publicado no J Neuroinflammation (2017)

Diagnosis of a multifocal B cell lymphoma with preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy

Por Kuhlmann, T, Schroter, A, Dechent, P, Weber, F, Rustenbeck, H, Fuzesi, L, Bruck, W, Ehrenreich, H, Frahm, J
Publicado em 2001

Moxifloxacin in the Therapy of Experimental Pneumococcal Meningitis

Por Schmidt, H., Dalhoff, A., Stuertz, K., Trostdorf, F., Chen, V., Schneider, O., Kohlsdorfer, C., Brück, W., Nau, R.
Publicado em 1998

p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis

Por Talos, F, Abraham, A, Vaseva, AV, Holembowski, L, Tsirka, SE, Scheel, A, Bode, D, Dobbelstein, M, Brück, W, Moll, UM
Publicado em 2010

Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease

Por Pittock, S, McClelland, R, Achenbach, S, Konig, F, Bitsch, A, Bruck, W, Lassmann, H, Parisi, J, Scheithauer, B, Rodriguez, M, Weinshenker, B, Lucchinetti, C
Publicado em 2005

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

Por Lucchinetti, C. F., Gavrilova, R. H., Metz, I., Parisi, J. E., Scheithauer, B. W., Weigand, S., Thomsen, K., Mandrekar, J., Altintas, A., Erickson, B. J., König, F., Giannini, C., Lassmann, H., Linbo, L., Pittock, S. J., Brück, W.
Publicado em 2008

Fatal PML associated with efalizumab therapy: Insights into integrin αLβ2 in JC virus control

Por Schwab, N., Ulzheimer, J.C., Fox, R.J., Schneider-Hohendorf, T., Kieseier, B.C., Monoranu, C.M., Staugaitis, S.M., Welch, W., Jilek, S., Du Pasquier, R.A., Brück, W., Toyka, K.V., Ransohoff, R.M., Wiendl, H.
Publicado em 2012

Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy

Por Fledrich, R., Abdelaal, T., Rasch, L., Bansal, V., Schütza, V., Brügger, B., Lüchtenborg, C., Prukop, T., Stenzel, J., Rahman, R. U., Hermes, D., Ewers, D., Möbius, W., Ruhwedel, T., Katona, I., Weis, J., Klein, D., Martini, R., Brück, W., Müller, W. C., Bonn, S., Bechmann, I., Nave, K. A., Stassart, R. M., Sereda, M. W.
Publicado no Nat Commun (2018)